LEONID ISKHAKOV: Open Payments
NPI 1700031770 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 66 payments from 17 companies in 2025. Trend: 2023 $1,022 · 2024 $1,201 · 2025 $1,867
Food & beverage: $1,867
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $544 |
| PFIZER INC. | 11 | $287 |
| Axsome Therapeutics, Inc. | 6 | $258 |
| Ipsen Biopharmaceuticals, Inc | 5 | $222 |
| Neurocrine BioSciences, Inc. | 6 | $187 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Amgen Inc. | 2 | $33 |
| Averitas Pharma Inc. | 1 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $28 |
Products named: QULIPTA, NURTEC ODT, Symbravo, Dysport, INGREZZA, BOTOX, GVOKE HYPOPEN, XIFAXAN.
Industry payments across NY — which companies pay providers there.
